Fosun Pharma unit starts China Phase II trial of COPD drug candidate FXS7553PUBT·Aug 13 at 04:38 AM02196-0.71%600196-1.46%
Fosun Pharma Subsidiary Wins Approval for Pediatric Constipation Drug in ChinaTip Ranks·Aug 3 at 05:13 AM02196-0.71%600196-1.46%
Fosun International Issues 1H2026 Positive Profit Alert as Core Industries Show Strong ResilienceAsian Corporate Newswire·Jul 30 at 07:35 PM00656+1.49%02196-0.71%
Fosun expects 1H profit attributable to owners at RMB 1.5 billion-RMB 1.8 billionPUBT·Jul 29 at 04:33 AM02196-0.71%00656+1.49%
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian marketsPUBT·Jul 16 at 06:33 AMVRAX-1.78%02196-0.71%
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement | VRAX Stock NewsStockTitan·Jul 15 at 10:30 PMVRAX-1.78%600196-1.46%
Fosun Pharma Shenzhen wins China approval to start Phase I trial of FXR0906 for hypertriglyceridemiaPUBT·Jul 15 at 05:14 AM02196-0.71%600196-1.46%
Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Gets a Hold from HSBCTip Ranks·Jul 13 at 07:27 PM600196-1.46%02196-0.71%
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watchrttnews·Jul 9 at 09:55 PMFBRX-0.01%CNTB-2.41%
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics | VRAX Stock NewsStockTitan·Jul 8 at 10:30 PMVRAX-1.78%02196-0.71%
Junshi Biosciences licenses JS005 rights in Greater China to Fosun Wanbang for CNY 215 million upfrontPUBT·Jul 1 at 06:28 AM688180-4.65%01877-1.36%
Fosun Pharma unit Fosun Adgenvax files for Hong Kong IPO in proposed spin-off listingPUBT·Jun 26 at 06:21 AM00656+1.49%600196-1.46%
FOSUN PHARMA Luvometinib Tablets Granted Approval for New IndicationAASTOCKS News·Jun 15 at 09:50 PM600196-1.46%02196-0.71%
FOSUN PHARMA Unit Fosun Antengene Raises Nearly RMB1B in Capital Increase, Prepares for Main Board ListingAASTOCKS News·Jun 15 at 09:45 PM06996-4.09%02196-0.71%
